Most Nigerian boards can tell you their revenue. Few can tell you how much of it will survive the next market disruption. Commercial resilience diagnostics are no longer optional - they are the missing instrument in board-level governance.
Updated November 2026 with full-year results for 2025.
Ask a board how much of its revenue would survive a sharp devaluation, the loss of its largest distributor or a well-funded competitor cutting prices for eighteen months, and the answer is usually an estimate, if it comes at all. That is not a failure of diligence. It reflects where board attention has been trained to go: towards compliance, credit and operational controls, the risks that enterprise risk frameworks inherited from banking regulation were built to catch. The risks that actually destroy corporate value sit elsewhere, in the durability of the commercial engine itself, and they rarely reach the board agenda until the damage is already in the accounts.
Boards watch the risks that rarely destroy value
When Booz & Company traced the 103 worst performers among 1,053 large listed companies over the decade from 2002, it found that strategic failure was the primary cause of value destruction in 81 per cent of cases. Compliance failures accounted for 9 per cent, operational failures for 7 per cent and external events for 3 per cent. An earlier Booz Allen Hamilton study of 1,200 companies between 1999 and 2003 reached the same conclusion from a different sample: 87 per cent of the value lost came from strategic and operational missteps, and only 13 per cent from compliance failures and lapses in board oversight combined.

None of this means compliance does not matter. A regulatory breach can end a business, and boards are right to police it. The issue is proportion. Board agendas, committee charters and risk registers are weighted heavily towards the 9 per cent, while the 81 per cent - weakening pricing power, a narrowing customer base, a competitor with a better model, a cost base priced in a currency the business does not earn - is left to management reports that describe performance rather than test whether it will last.
Nigeria's recent results show what the revenue line hides
The past two years have given Nigerian boards an unusually clear lesson. After the naira was floated in June 2023, several of the country's best-known consumer businesses grew revenue by between 60 and 88 per cent in 2024 and still reported pre-tax losses, largely because obligations in foreign currency became far more expensive. In 2025, as the currency steadied, the same businesses returned to profit, a turnaround that reflects real work by their management teams on pricing, costs and financing. Nestlé Nigeria moved from a pre-tax loss of ₦221.6 billion to a profit of ₦166.8 billion, and Nigerian Breweries from a loss of ₦182.9 billion to a profit of ₦161.1 billion. International Breweries and Cadbury Nigeria followed the same path.

The recovery is good news, and none of this is a criticism of these companies. The lesson for boards lies in the size of the swing. Revenue grew in both years, so the revenue line gave no warning of either the losses or the recovery. What moved the results sat beneath it: how much of the cost base and the balance sheet was tied to a currency the business does not earn, and how far prices could rise before volume gave way. In 2024 Nestlé Nigeria's cost of sales rose by 98 per cent against revenue growth of 75 per cent, and its gross margin fell from about 40 per cent to about 32 per cent; in 2025 it recovered to about 36 per cent.
Any board would have discussed currency risk through this period. The harder questions are the ones a risk register is not designed to answer: how much of the business model depends on a stable naira, how quickly the supply base could be restructured, and what margin the company could defend if the currency moved sharply again. Those are questions of commercial resilience, and answering them needs a different instrument.
Risk registers ask what could go wrong. Resilience asks what holds the business up
A conventional risk assessment starts from events: what could happen, how likely it is and what it would cost. A commercial resilience diagnostic starts from the business: what creates its revenue and margin today, and how much stress each of those mechanisms can bear. The distinction matters because an organisation can keep a clean risk register while its commercial foundations erode beneath it. Results can be carried for several years by momentum - an established brand, a legacy distribution network, customers who have not yet found an alternative - long after the advantage that built them has gone.
Five questions every board should be able to answer
An effective diagnostic examines five dimensions. Each is assessed with hard metrics and structured judgement, and each comes down to a question the board should be able to answer at any meeting, not only at the annual strategy retreat.
Revenue concentration. How much of our revenue would be at risk if we lost our largest customer, product, channel or market in a single quarter? The test covers exposure to individual distributors, key accounts, product lines and geographies, and shows where one adverse event would do disproportionate damage.
Pricing power. If our input costs rose by 30 per cent, how much could we pass on, and what would happen to volume? This is the dimension that 2024 tested hardest, and the one 2025 rewarded. It measures the ability to hold margin against cost inflation, currency movements, competitor pricing and the bargaining power of large buyers.
Competitive position. Is our market share being earned or inherited? The analysis tracks the direction of our share and that of our strongest competitors, and the likelihood of a new entrant arriving with a lower cost base or a different business model.
Adaptability. How quickly could we change what we sell, how we source it and how we take it to market? This covers the product pipeline, the capacity to reconfigure supply and the company's record of delivering change rather than announcing it.
Commercial bench strength. If our two most senior commercial leaders left, would performance hold? It assesses the depth of commercial leadership, the effectiveness of the sales force and the quality of pricing and marketing capability below the top team.
The output is a scorecard that shows where the business is strong and where it is exposed, and it should be read as a pattern rather than an average. A business that scores well on four dimensions and poorly on pricing power has a specific weakness that can be fixed. A business that scores moderately on all five may have a deeper problem with its strategic position. Both can report strong results in the current year.
Three conditions that make the diagnostic work
Independence. The assessment should not be carried out by the management team reporting on its own performance. An external view benchmarks the business against relevant comparators and removes the optimism that colours any self-assessment. This is not a judgement on management; it is the same logic that places the external auditor outside the finance function.
Regularity. Commercial resilience changes as markets change. A single diagnostic is a snapshot. An annual assessment, refreshed whenever a material shock occurs, shows the board which way the business is moving and where new exposures are forming.
Consequence. The findings must feed directly into strategic planning, the budget and capital allocation. A diagnostic that is presented, noted and filed is a governance ritual. One that changes where money is spent is a governance instrument.
For those constituting a board
A board that is being formed or refreshed has an advantage: it can build commercial oversight into its structure from the start rather than add it after a crisis. Three choices matter most.
Compose for commercial judgement. Nigerian boards are often strong on legal, accounting and regulatory expertise and thinner on directors who have run a profit and loss account, set prices through high inflation or built a distribution network. At least one non-executive director should bring that operating experience, and the nomination process should test for it explicitly.
Give commercial risk a home. Most boards place risk with an audit or risk committee whose charter, in practice, centres on financial controls and compliance. Either widen that charter to name commercial risk, or establish a strategy committee that owns the resilience diagnostic and reports on it to the full board.
Put it on the calendar. Agree from the first year that the board will receive a commercial resilience review every year, alongside the audited accounts, and that the strategy and budget cycle will respond to it. What is scheduled gets discussed. What is left to management discretion tends to reach the board only after something has gone wrong.
The implication for boards
The cost of a thorough commercial resilience diagnostic is a small fraction of the value it protects, and the recent results give a sense of scale: the pre-tax results of four established companies swung by close to ₦1 trillion over two years, driven largely by exposures the revenue line did not show. Boards that adopt the discipline will oversee the risks that actually move shareholder value, and they will be better placed to guide management in building the pricing power, supply flexibility and commercial depth that the next shock will test.
There is a simple test any board can apply to itself. Compare the time its last four meetings gave to compliance and controls with the time they gave to the durability of the company's revenue and margin. If the first is larger, the board's attention is weighted towards the risks that cause less than one loss in ten, and the business is most exposed where its oversight is weakest.
Sources
- Booz & Company (Christopher Dann, Matthew Le Merle and Christopher Pencavel), The Root Causes of Value Destruction, 2012, and The Lesson of Lost Value, strategy+business, 27 November 2012 (1,053 companies with enterprise value above US$1 billion on 1 January 2002; the 103 worst performers over ten years; strategic failure the primary cause in 81 per cent of cases, compliance 9, operational 7, external 3)
- Paul Kocourek, Jim Newfrock and Reggie Van Lee, SOX Rocks, but Won't Block Shocks, strategy+business, 1 March 2005 (1,200 companies above US$1 billion market capitalisation, 1999 to 2003; 87 per cent of value lost to strategic and operational missteps, 13 per cent to compliance failures and poor board oversight)
- Nairametrics, Nestlé Nigeria results for 2024 (27 February 2025) and 2025 (26 February 2026) (2024: revenue ₦958.8 billion, up 75.25 per cent; cost of sales up 97.75 per cent; loss before tax ₦221.6 billion. 2025: revenue ₦1.2 trillion, up 26 per cent; gross profit ₦435.9 billion; profit before tax ₦166.8 billion)
- Nairametrics, Nigerian Breweries results for 2024 (15 February 2025) and 2025 (13 February 2026) (2024: revenue ₦1.08 trillion, up 80.8 per cent; loss before tax ₦182.9 billion; net foreign exchange loss ₦157.5 billion. 2025: revenue ₦1.467 trillion, up 35.3 per cent; profit before tax ₦161.1 billion)
- Nairametrics, International Breweries results for 2024 (4 April 2025) and audited 2025 (10 April 2026) (2024: revenue ₦488.9 billion, up 87.63 per cent; loss before tax ₦111.8 billion. 2025: revenue ₦619.0 billion, up 26.6 per cent; profit before tax ₦88.95 billion)
- Nairametrics, Cadbury Nigeria results for 2024 (2 April 2025) and unaudited 2025 (27 January 2026) (2024: revenue ₦129.1 billion, up from ₦80.3 billion; loss before tax ₦28.3 billion. 2025: revenue ₦169.8 billion, up 31.49 per cent; profit before tax ₦17.2 billion)
If you would like to discuss a commercial resilience diagnostic for your board, please get in touch at info@carthenaadvisory.com.
Related serviceStrategy consulting and implementationTransformation Advisory



